Literature DB >> 21742210

Epidemiology of ARDS and ALI.

Ross Blank1, Lena M Napolitano.   

Abstract

Acute respiratory distress syndrome (ARDS) and acute lung injury (ALI) are distinctly modern clinical entities. Recent epidemiologic research has taken advantage of large cohorts in efforts to better describe these highly lethal syndromes with a focus on differentiation of clinically meaningful subtypes and early prediction in an effort to improve treatment and prevention. This article identifies the most significant studies and systematic reviews of recent years, defining the incidence, mortality, risk and prognostic factors, and etiologic classes of ARDS/ALI.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21742210     DOI: 10.1016/j.ccc.2011.05.005

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  44 in total

Review 1.  Prompting physicians to address a daily checklist for antibiotics: do we need a co-pilot in the ICU?

Authors:  Curtis H Weiss; Richard G Wunderink
Journal:  Curr Opin Crit Care       Date:  2013-10       Impact factor: 3.687

2.  Chemokine (C-X-C motif) receptor 4 regulates lung endothelial barrier permeability during resuscitation from hemorrhagic shock.

Authors:  F S Babu; H M LaPorte; S P Nassoiy; M Majetschak
Journal:  Physiol Res       Date:  2019-06-06       Impact factor: 1.881

Review 3.  Toward Smarter Lumping and Smarter Splitting: Rethinking Strategies for Sepsis and Acute Respiratory Distress Syndrome Clinical Trial Design.

Authors:  Hallie C Prescott; Carolyn S Calfee; B Taylor Thompson; Derek C Angus; Vincent X Liu
Journal:  Am J Respir Crit Care Med       Date:  2016-07-15       Impact factor: 21.405

4.  Prothrombin is a binding partner of the human receptor of advanced glycation end products.

Authors:  Genny Degani; Alessandra Altomare; Stefania Digiovanni; Beatrice Arosio; Guenter Fritz; Angela Raucci; Giancarlo Aldini; Laura Popolo
Journal:  J Biol Chem       Date:  2020-07-14       Impact factor: 5.157

5.  Cytoprotection of perfluorocarbon on PMVECs in vitro.

Authors:  Shufeng Xu; Ping Wang; Kun Wei; Fengsui Liu; Zhixin Liang; Xiaowei Zhao; Aimin Li; Liangan Chen
Journal:  Inflammation       Date:  2013-04       Impact factor: 4.092

6.  IL1RN coding variant is associated with lower risk of acute respiratory distress syndrome and increased plasma IL-1 receptor antagonist.

Authors:  Nuala J Meyer; Rui Feng; Mingyao Li; Yang Zhao; Chau-Chyun Sheu; Paula Tejera; Robert Gallop; Scarlett Bellamy; Melanie Rushefski; Paul N Lanken; Richard Aplenc; Grant E O'Keefe; Mark M Wurfel; David C Christiani; Jason D Christie
Journal:  Am J Respir Crit Care Med       Date:  2013-05-01       Impact factor: 21.405

7.  CaMKIα regulates AMP kinase-dependent, TORC-1-independent autophagy during lipopolysaccharide-induced acute lung neutrophilic inflammation.

Authors:  Lanping Guo; Jennifer L Stripay; Xianghong Zhang; Richard D Collage; Mei Hulver; Evie H Carchman; Gina M Howell; Brian S Zuckerbraun; Janet S Lee; Matthew R Rosengart
Journal:  J Immunol       Date:  2013-02-27       Impact factor: 5.422

8.  Electroporation-mediated delivery of genes in rodent models of lung contusion.

Authors:  David Machado-Aranda; Krishnan Raghavendran
Journal:  Methods Mol Biol       Date:  2014

9.  Epigenetic contribution of the myosin light chain kinase gene to the risk for acute respiratory distress syndrome.

Authors:  Keely L Szilágyi; Cong Liu; Xu Zhang; Ting Wang; Jeffrey D Fortman; Wei Zhang; Joe G N Garcia
Journal:  Transl Res       Date:  2016-08-01       Impact factor: 7.012

10.  Long-chain acyl-CoA dehydrogenase deficiency as a cause of pulmonary surfactant dysfunction.

Authors:  Eric S Goetzman; John F Alcorn; Sivakama S Bharathi; Radha Uppala; Kevin J McHugh; Beata Kosmider; Rimei Chen; Yi Y Zuo; Megan E Beck; Richard W McKinney; Helen Skilling; Kristen R Suhrie; Anuradha Karunanidhi; Renita Yeasted; Chikara Otsubo; Bryon Ellis; Yulia Y Tyurina; Valerian E Kagan; Rama K Mallampalli; Jerry Vockley
Journal:  J Biol Chem       Date:  2014-03-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.